国际标准期刊号: 2161-119X

耳鼻喉科:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Mucociliary Clearance: Measures and Therapies

Murray Grossan

Mucociliary Clearance can be measured clinically with the Saccharine Test in the sino-nasal system. When clearance is slow, treat mucus viscosity and slow ciliary beat frequency. Chronic sinusitis and bronchitis are often due to poor MCC. Therapy to upper or lower respiratory system benefits both. Therapy for Mucociliary Clearance includes proteolytic enzymes to reduce mucus viscosity, vibrations for improving ciliary beat frequency, irrigation with Locke-Ringer's solution for cilia frequency, glucosteroids and surfactants. Use of the Saccharine Test can help determine toxic effects of chromium, Sulphur Dioxide, benzines and other toxic products. In acute allergy, mucociliary clearance speeds up; but sinusitis may follow when mucociliary clearnace slows down later. In slow mucociliary clearance, bacteria remain in place and are able to multiply. This is a significant factor for recurrent sinus infections and indicates a method of treatment that includes restoring normal mucociliary clearance (MCC). Measuring MCC in the lower respiratory tract is complex and includes inhalation of radioactive particles. Clinically, the results of the Saccharine test of the nasal system may be an indicator of the MCC in the lower respiratory system.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。